In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug ...

drugs, surgical procedures or devices. Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which ...